Previous 10 | Next 10 |
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, has received...
JERUSALEM, Nov. 03, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment o...
Psoriasis is a skin condition that causes individuals to develop a rash with scaly, itchy patches on their elbows, knees, trunk and scalp. This chronic illness, which may start off as a few itchy patches, can severely affect an individual’s quality of life. Psoriasis is often accompanie...
Scinai Immunotherapeutics Ltd. (SCNI) is expected to report for Q3 2023
2023-11-01 03:07:45 ET More on Scinai Immunotherapeutics Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Historical earnings data for Scinai Immunotherapeutics Financial information for Scinai Immunotherapeutics For further details see: S...
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is repo...
Recently rebranded Scinai Immunotherapeutics shifted drug development focus from COVID-19 antibody to a novel antibody for the treatment of psoriasis and launched a CDMO business unit Adjusted terms being considered by EIB would extend maturity of finance facility and improve shareholders...
JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoi...
2023-10-30 17:28:10 ET More on Scinai Immunotherapeutics Ltd. Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Ltd. Historical earnings data for Scinai Immunotherapeutics Ltd. Financial information for Scinai Immunotherapeutics Ltd. For furthe...
Researchers from the University of Southampton, United Kingdom and La Jolla Institute for Immunology (LJI) have identified a group of immune cells that may be responsible for severe asthma. Identified as cytotoxic CD4+ tissue-resident memory T cells , these cells congregate in the lungs ...
News, Short Squeeze, Breakout and More Instantly...
Scanner Technologies Corp Company Name:
SCNI Stock Symbol:
OTCMKTS Market:
Scanner Technologies Corp Website:
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservic...
Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb PR Newswire Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the Paul Erlich Institute (the PEI) for its...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...